Recap: Applied DNA Sciences Q4 Earnings

Shares of Applied DNA Sciences (NASDAQ:APDN) fell 21.15% after the company reported Q4 results.

Quarterly Results

Earnings per share rose 43.06% year over year to ($0.82), which missed the estimate of ($0.52).

Revenue of $314,000 declined by 81.53% year over year, which missed the estimate of $710,000.

Guidance

Applied DNA Sciences hasn't issued any earnings guidance for the time being.

Applied DNA Sciences hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Dec 17, 2020

Time: 04:30 PM

ET Webcast URL: https://78449.choruscall.com/dataconf/productusers/apdn/mediaframe/41903/indexr.html

Price Action

Company's 52-week high was at $16.39

52-week low: $2.52

Price action over last quarter: down 37.90%

Company Description

Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.